Literature DB >> 9738209

Three-dimensional visualization of physiologically based kinetic model outputs.

J Nichols1, P Rheingans, D Lothenbach, R McGeachie, L Skow, J McKim.   

Abstract

Outputs from a physiologically based toxicokinetic (PB-TK) model for fish were visualized by mapping time-series data for specific tissues onto a three-dimensional representation of a rainbow trout. The trout representation was generated in stepwise fashion: 1) cross-section images were obtained from an anesthetized fish using a magnetic resonance imaging system, 2) images were processed to classify tissue types and eliminate unnecessary detail. 3) processed images were imported to a visualization software package (Application Visualization System) to create a three-dimensional representation of the fish, encapsulating five volumes corresponding to the liver, kidney, muscle, gastrointestinal tract, and fat, Kinetic data for the disposition of pentachloroethane in trout were generated using a PB-TK model. Model outputs were mapped onto corresponding tissues volumes, representing chemical concentration as color intensity. The workstation software was then used to animate the images, illustration the accumulation of pentachloroethane in each tissue during a continuous branchial (gill) exposure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 9738209      PMCID: PMC1567460          DOI: 10.1289/ehp.94102952

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  13 in total

1.  Pharmacokinetic modeling of the dogfish shark (Squalus acanthias): distribution and urinary and biliary excretion of phenol red and its glucuronide.

Authors:  P M Bungay; R L Dedrick; A M Guarino
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

Review 2.  Development and utilization of physiologically based pharmacokinetic models for toxicological applications.

Authors:  H W Leung
Journal:  J Toxicol Environ Health       Date:  1991-03

3.  Prediction of the distribution of methotrexate in the sting rays Dasyatidae sabrina and sayi by use of a model developed in mice.

Authors:  D S Zaharko; R L Dedrick; V T Oliverio
Journal:  Comp Biochem Physiol A Comp Physiol       Date:  1972-05-01

4.  Development of a physiologically based pharmacokinetic model for risk assessment with 1,4-dioxane.

Authors:  R H Reitz; P S McCroskey; C N Park; M E Andersen; M L Gargas
Journal:  Toxicol Appl Pharmacol       Date:  1990-08       Impact factor: 4.219

5.  A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans.

Authors:  J C Ramsey; M E Andersen
Journal:  Toxicol Appl Pharmacol       Date:  1984-03-30       Impact factor: 4.219

Review 6.  Physiologically based pharmacokinetic modeling: principles and applications.

Authors:  L E Gerlowski; R K Jain
Journal:  J Pharm Sci       Date:  1983-10       Impact factor: 3.534

7.  Pharmacokinetics of tetrachloroethylene.

Authors:  R C Ward; C C Travis; D M Hetrick; M E Andersen; M L Gargas
Journal:  Toxicol Appl Pharmacol       Date:  1988-03-30       Impact factor: 4.219

8.  Pharmacokinetics, biochemical mechanism and mutation accumulation: a comprehensive model of chemical carcinogenesis.

Authors:  R B Conolly; R H Reitz; H J Clewell; M E Andersen
Journal:  Toxicol Lett       Date:  1988-10       Impact factor: 4.372

9.  An in vitro gas equilibration method for determination of chemical partition coefficients in fish.

Authors:  A D Hoffman; S L Bertelsen; M L Gargas
Journal:  Comp Biochem Physiol A Comp Physiol       Date:  1992

10.  Physiologically based pharmacokinetics and the risk assessment process for methylene chloride.

Authors:  M E Andersen; H J Clewell; M L Gargas; F A Smith; R H Reitz
Journal:  Toxicol Appl Pharmacol       Date:  1987-02       Impact factor: 4.219

View more
  1 in total

1.  PAVA: physiological and anatomical visual analytics for mapping of tissue-specific concentration and time-course data.

Authors:  Michael-Rock Goldsmith; Thomas R Transue; Daniel T Chang; Rogelio Tornero-Velez; Michael S Breen; Curtis C Dary
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-05-22       Impact factor: 2.745

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.